A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.
Yvonne BombardFiona Alice MillerCarolyn J BargSarah J PattonJune C CarrollPranesh ChakrabortyBeth K PotterKaren TamLouise TaylorElizabeth N KerrChristine DaviesJennifer MilburnFelix RatjenAstrid GuttmannRobin Z HayeemsPublished in: Genetics in medicine : official journal of the American College of Medical Genetics (2016)
Although mothers valued learning carrier results from NBS, they reported moderate uptake of carrier testing and limited influence on family planning. Our study highlights the secondary nature of the benefit of disclosing carrier results of NBS.Genet Med 19 4, 403-411.